Appointed
Andrew Gu
Class III Director
CLRB ·
Cellectar Biosciences, Inc.
On May 18, 2026, the Board appointed Mr. Gu to serve as a member of the Board as a Class III director.
Executive movement radar
Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 2901–2950 of 76231
Appointed
(interim)
Claude F. Russ
Interim Chief Accounting Officer
FDX ·
FEDEX CORP
The Board of Directors of FedEx has appointed Claude F. Russ, who currently serves as the Company’s Enterprise Vice President, Finance and was recently named to serve as the Company’s Interim Chief Financial Officer effective June 1, 2026, to serve as the Company’s Interim Chief Accounting Officer, effective June 1, 2026, until the appointment of Mr. Erwin’s permanent successor.
Departed
Guy M. Erwin II
Chief Accounting Officer
FDX ·
FEDEX CORP
On May 14, 2026, Guy M. Erwin II, Corporate Vice President and Chief Accounting Officer of FedEx Corporation (“FedEx” or the “Company”), informed the Company that he is resigning, effective May 31, 2026, to join FedEx Freight Holding Company, Inc. as Senior Vice President – Chief Accounting Officer.
Appointed
Coley O'Brien
Chief Human Resources Officer
BLDR ·
Builders FirstSource, Inc.
the Board appointed Coley O'Brien to succeed Mr. Hiller as Chief Human Resources Officer, effective May 18, 2026.
Departed
Steve Herron
Chief Operating Officer
BLDR ·
Builders FirstSource, Inc.
Mr. Herron has served as Chief Operating Officer of the Company since March 2023 and is retiring after over 15 years of dedicated service to the Company.
Appointed
Mike Hiller
Chief Operating Officer-Designate
BLDR ·
Builders FirstSource, Inc.
appointed Mike Hiller, Chief Talent Officer of the Company, as Chief Operating Officer-Designate effective May 18, 2026.
Appointed
Lauren StClair
Director
MAX ·
MediaAlpha, Inc.
On May 15, 2026, the Board of Directors (the “Board”) of MediaAlpha, Inc. (the “Company”) appointed Lauren StClair as a member of the Board, filling the existing vacancy in Class I of the Board.
Departed
Kah Loong Randy Yeo
Director
YHC ·
LQR House Inc.
On May 12, 2026, Kah Loong Randy Yeo resigned from the Board of Directors of LQR House Inc. (the “ Company ”), effective immediately.
Departed
Don Clegg
Senior Vice President of Worldwide Sales
SMCI ·
Super Micro Computer, Inc.
On May 12, 2026, Mr. Don Clegg, Senior Vice President of Worldwide Sales, informed Super Micro Computer, Inc. (the “Company”) that he will retire effective May 15, 2026.
Appointed
Peter O'Rourke
Director
QUCY ·
Quantum Cyber N.V.
Effective as of May 13, 2026, to fill vacancy in the composition of the Board of Directors (the “Board”), the Board of the Company appointed Peter O’Rourke to serve as a director
Appointed
Joseph Shaposhnik
Independent Director
MKLY ·
McKinley Acquisition Corp
On May 14, 2026, the holders of Class B ordinary shares in McKinley Acquisition Corporation (the “Company”) appointed Joseph Shaposhnik as an additional independent director of the Company, and Mr. Shaposhnik consented to such appointment.
Appointed
P. Darryl Rensmon
President
EBMT ·
Eagle Bancorp Montana, Inc.
the Board decided to split the roles of Chief Executive Officer and President and has appointed P. Darryl Rensmon, the current EVP and Chief Operating Officer, as President effective June 1, 2026.
Role change
Laura F. Clark
President
EBMT ·
Eagle Bancorp Montana, Inc.
In anticipation of the future retirement of current President and Chief Executive Officer, Laura F. Clark, the Board decided to split the roles of Chief Executive Officer and President
Appointed
Eric L. Veiel
President, Co-Head of Global Investments and Chief Investment Officer
TROW ·
PRICE T ROWE GROUP INC
On May 15, 2026, the Board of Directors (the “Board”) of T. Rowe Price Group, Inc. (the “Company”) approved the appointment of Eric L. Veiel to become the President, Co-Head of Global Investments and Chief Investment Officer of the Company, effective immediately.
Departed
Jeremy Krol
Director
PHUN ·
Phunware, Inc.
On May 12, 2026, Jeremy Krol notified the Company of his voluntary resignation from the Board of Directors.
Role change
Jeremy Krol
Chief Operating Officer
PHUN ·
Phunware, Inc.
the Company and Mr. Krol agreed to the transition of Mr. Krol back into his role as Chief Operating Officer
Appointed
Dmitry Kroshka
Chief Executive Officer
PHUN ·
Phunware, Inc.
On May 12, 2026, the Board of Directors appointed Dmitry Kroshka as Chief Executive Officer of the Company.
Departed
Rick Gordon
Director
Tri-State Generation & Transmission Association, Inc.
certified the election by its member, Mountain View Electric Association, Inc. (“MVEA”), of James Riggins to replace Rick Gordon, as the director representing MVEA on Tri-State’s Board of Directors effective as of June 4, 2026.
Appointed
James Riggins
Director
Tri-State Generation & Transmission Association, Inc.
certified the election by its member, Mountain View Electric Association, Inc. (“MVEA”), of James Riggins to replace Rick Gordon, as the director representing MVEA on Tri-State’s Board of Directors effective as of June 4, 2026.
Appointed
Brigette Roberts
Director
QNCX ·
Quince Therapeutics, Inc.
Brigette Roberts, M.D., was appointed to the Board as a Class III director.
Appointed
Brigette Roberts
Chief of Corporate Affairs
QNCX ·
Quince Therapeutics, Inc.
Dr. Roberts was also appointed as the Chief of Corporate Affairs of the Company.
Departed
Patricia Hirano
Senior Vice President, Regulatory Affairs
SLNO ·
SOLENO THERAPEUTICS INC
each of Anish Bhatnagar, M.D. (Chief Executive Officer), Jennifer Fulk (Chief Financial Officer), Patricia Hirano (Senior Vice President, Regulatory Affairs), Kristen Yen (Senior Vice President, Global Clinical Operations & Patient Advocacy), Meredith Manning (Chief Commercial Officer), Manher (AJ) Joshi (Chief Development Officer), Kevin Norrett (Chief Business Officer) and Michael Huang (Senior Vice President, Clinical Development) resigned from his or her positions as an officer
Departed
Mark Hahn
Director
SLNO ·
SOLENO THERAPEUTICS INC
each of Anish Bhatnagar, M.D., Mark Hahn, Matthew Pauls, Birgitte Volck, Andrew Sinclair and Dawn Bir resigned from his or her respective positions as a member of the Company’s board of directors
Departed
Andrew Sinclair
Director
SLNO ·
SOLENO THERAPEUTICS INC
each of Anish Bhatnagar, M.D., Mark Hahn, Matthew Pauls, Birgitte Volck, Andrew Sinclair and Dawn Bir resigned from his or her respective positions as a member of the Company’s board of directors
Departed
Anish Bhatnagar
Chief Executive Officer
SLNO ·
SOLENO THERAPEUTICS INC
each of Anish Bhatnagar, M.D. (Chief Executive Officer), Jennifer Fulk (Chief Financial Officer), Patricia Hirano (Senior Vice President, Regulatory Affairs), Kristen Yen (Senior Vice President, Global Clinical Operations & Patient Advocacy), Meredith Manning (Chief Commercial Officer), Manher (AJ) Joshi (Chief Development Officer), Kevin Norrett (Chief Business Officer) and Michael Huang (Senior Vice President, Clinical Development) resigned from his or her positions as an officer
Departed
Anish Bhatnagar
Director
SLNO ·
SOLENO THERAPEUTICS INC
each of Anish Bhatnagar, M.D., Mark Hahn, Matthew Pauls, Birgitte Volck, Andrew Sinclair and Dawn Bir resigned from his or her respective positions as a member of the Company’s board of directors
Departed
Kristen Yen
Senior Vice President, Global Clinical Operations & Patient Advocacy
SLNO ·
SOLENO THERAPEUTICS INC
each of Anish Bhatnagar, M.D. (Chief Executive Officer), Jennifer Fulk (Chief Financial Officer), Patricia Hirano (Senior Vice President, Regulatory Affairs), Kristen Yen (Senior Vice President, Global Clinical Operations & Patient Advocacy), Meredith Manning (Chief Commercial Officer), Manher (AJ) Joshi (Chief Development Officer), Kevin Norrett (Chief Business Officer) and Michael Huang (Senior Vice President, Clinical Development) resigned from his or her positions as an officer
Appointed
Darin M. Lippoldt
President and Secretary
SLNO ·
SOLENO THERAPEUTICS INC
the officers of the Company are as follows: Darin M. Lippoldt (President and Secretary) and Matthew C. Abernethy (Treasurer and Vice President).
Departed
Matthew Pauls
Director
SLNO ·
SOLENO THERAPEUTICS INC
each of Anish Bhatnagar, M.D., Mark Hahn, Matthew Pauls, Birgitte Volck, Andrew Sinclair and Dawn Bir resigned from his or her respective positions as a member of the Company’s board of directors
Departed
Jennifer Fulk
Chief Financial Officer
SLNO ·
SOLENO THERAPEUTICS INC
each of Anish Bhatnagar, M.D. (Chief Executive Officer), Jennifer Fulk (Chief Financial Officer), Patricia Hirano (Senior Vice President, Regulatory Affairs), Kristen Yen (Senior Vice President, Global Clinical Operations & Patient Advocacy), Meredith Manning (Chief Commercial Officer), Manher (AJ) Joshi (Chief Development Officer), Kevin Norrett (Chief Business Officer) and Michael Huang (Senior Vice President, Clinical Development) resigned from his or her positions as an officer
Departed
Kevin Norrett
Chief Business Officer
SLNO ·
SOLENO THERAPEUTICS INC
each of Anish Bhatnagar, M.D. (Chief Executive Officer), Jennifer Fulk (Chief Financial Officer), Patricia Hirano (Senior Vice President, Regulatory Affairs), Kristen Yen (Senior Vice President, Global Clinical Operations & Patient Advocacy), Meredith Manning (Chief Commercial Officer), Manher (AJ) Joshi (Chief Development Officer), Kevin Norrett (Chief Business Officer) and Michael Huang (Senior Vice President, Clinical Development) resigned from his or her positions as an officer
Appointed
Matthew C. Abernethy
Treasurer and Vice President
SLNO ·
SOLENO THERAPEUTICS INC
the officers of the Company are as follows: Darin M. Lippoldt (President and Secretary) and Matthew C. Abernethy (Treasurer and Vice President).
Appointed
Matthew C. Abernethy
Director
SLNO ·
SOLENO THERAPEUTICS INC
Immediately following the Effective Time, Matthew C. Abernethy and Darin M. Lippoldt became the directors of the Company
Departed
Meredith Manning
Chief Commercial Officer
SLNO ·
SOLENO THERAPEUTICS INC
each of Anish Bhatnagar, M.D. (Chief Executive Officer), Jennifer Fulk (Chief Financial Officer), Patricia Hirano (Senior Vice President, Regulatory Affairs), Kristen Yen (Senior Vice President, Global Clinical Operations & Patient Advocacy), Meredith Manning (Chief Commercial Officer), Manher (AJ) Joshi (Chief Development Officer), Kevin Norrett (Chief Business Officer) and Michael Huang (Senior Vice President, Clinical Development) resigned from his or her positions as an officer
Departed
Manher (AJ) Joshi
Chief Development Officer
SLNO ·
SOLENO THERAPEUTICS INC
each of Anish Bhatnagar, M.D. (Chief Executive Officer), Jennifer Fulk (Chief Financial Officer), Patricia Hirano (Senior Vice President, Regulatory Affairs), Kristen Yen (Senior Vice President, Global Clinical Operations & Patient Advocacy), Meredith Manning (Chief Commercial Officer), Manher (AJ) Joshi (Chief Development Officer), Kevin Norrett (Chief Business Officer) and Michael Huang (Senior Vice President, Clinical Development) resigned from his or her positions as an officer
Departed
Birgitte Volck
Director
SLNO ·
SOLENO THERAPEUTICS INC
each of Anish Bhatnagar, M.D., Mark Hahn, Matthew Pauls, Birgitte Volck, Andrew Sinclair and Dawn Bir resigned from his or her respective positions as a member of the Company’s board of directors
Departed
Michael Huang
Senior Vice President, Clinical Development
SLNO ·
SOLENO THERAPEUTICS INC
each of Anish Bhatnagar, M.D. (Chief Executive Officer), Jennifer Fulk (Chief Financial Officer), Patricia Hirano (Senior Vice President, Regulatory Affairs), Kristen Yen (Senior Vice President, Global Clinical Operations & Patient Advocacy), Meredith Manning (Chief Commercial Officer), Manher (AJ) Joshi (Chief Development Officer), Kevin Norrett (Chief Business Officer) and Michael Huang (Senior Vice President, Clinical Development) resigned from his or her positions as an officer
Appointed
Darin M. Lippoldt
Director
SLNO ·
SOLENO THERAPEUTICS INC
Immediately following the Effective Time, Matthew C. Abernethy and Darin M. Lippoldt became the directors of the Company
Departed
Dawn Bir
Director
SLNO ·
SOLENO THERAPEUTICS INC
each of Anish Bhatnagar, M.D., Mark Hahn, Matthew Pauls, Birgitte Volck, Andrew Sinclair and Dawn Bir resigned from his or her respective positions as a member of the Company’s board of directors
Appointed
Danielle Porto Parra
President
XPOF ·
Xponential Fitness, Inc.
On May 18, 2026, Xponential Fitness, Inc. (the “Company”), issued a press release (the “Press Release”), announcing the appointment of Danielle Porto Parra as its President, effective as of May 18, 2026.
Appointed
Eugene Davis
Director
NOTV ·
Inotiv, Inc.
appointed Eugene Davis and John T. Young, Jr. to the Board
Appointed
John T. Young, Jr.
Director
NOTV ·
Inotiv, Inc.
appointed Eugene Davis and John T. Young, Jr. to the Board
Appointed
Gregory Martini
Chief Financial Officer
KYTX ·
Kyverna Therapeutics, Inc.
On May 14, 2026, the Board of Directors (the “Board”) of Kyverna Therapeutics, Inc. (the “Company”) appointed Gregory Martini as the Company’s Chief Financial Officer, effective May 18, 2026 (the “Effective Date”).
Role change
Armando Pimentel, Jr.
Vice Chairman
NEE ·
NEXTERA ENERGY INC
Armando Pimentel, Jr., Chief Executive Officer of Florida Power & Light Company (FPL) and a named executive officer of NextEra Energy, Inc. (NEE), resigned from such position effective May 18, 2026 and was appointed Vice Chairman of NEE effective May 18, 2026.
Departed
Nicola Rossi
Chief Accounting Officer
WH ·
WYNDHAM HOTELS & RESORTS, INC.
On July 31, 2026 (the “Effective Date”), Nicola Rossi, Chief Accounting Officer of Wyndham Hotels & Resorts, Inc. (the “Company”), will depart from the Company.
Appointed
Christopher Androski
Chief Accounting Officer
WH ·
WYNDHAM HOTELS & RESORTS, INC.
As of the Effective Date, Christopher Androski, age 52, who is currently the Company’s Senior Vice President and Controller, will assume the role of Chief Accounting Officer.
Appointed
Jan Stern Reed
Director
GMRS ·
GMR Solutions Inc.
Effective May 12, 2026, each of Jan Stern Reed and Timothy Wicks were appointed to the Board of Directors of the Company
Appointed
Timothy Wicks
Director
GMRS ·
GMR Solutions Inc.
Effective May 12, 2026, each of Jan Stern Reed and Timothy Wicks were appointed to the Board of Directors of the Company
Appointed
Ivona Smith
Director
BTM ·
Bitcoin Depot Inc.
On May 13, 2026, the Board of Directors (the “Board”) of the Company, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Ivona Smith to the Board, effective May 13, 2026.
Departed
Scott S. Prince
Director
ARI ·
Apollo Commercial Real Estate Finance, Inc.
On May 14, 2026, Scott S. Prince, a director on the Board of Directors (the “Board”) of Apollo Commercial Real Estate Finance, Inc. (the “Company”), informed the Company that he will not be standing for re-election to the Board at the Company’s next annual meeting of stockholders.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.